跳至主要内容
临床试验/IRCT201307305283N8
IRCT201307305283N8已完成未知

The effect of vaginal Danazol versus gonadtropin-releazing hormone agonists in the management of intractable uterine hemorrhage during and post operative hysteroscopy

Tabriz University of Medical Sciences, Vice chancellor for Research0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 50 years(—)
性别
Female

入选标准

  • Women in reproductive age with moderate abnormal uterine bleeding which is resistant to drugs, caused by endometrial hyperplasia; endometrial polyps; submucosal myomas less than 4 cm in size.
  • Exclusion criteria: Patients with Heart, Lung, Renal, Liver disease; Patients with metabolic disease like hypertension, hyperlipidemia, hyperglycemia; Patients with cervical cancers; uterine cancers; submucosal myomas larger than 4 cm in size; Uterine septum; Pregnant women; Patients with genial tract infections; Patients using Anti coagulant drugs; Patients with sever uterine bleeding.

排除标准

  • 未提供

研究者

发起方
Tabriz University of Medical Sciences, Vice chancellor for Research

相似试验